Plasma-derived Immunoglobulins

About Grifols

Grifols is a Spanish multinational pharmaceutical and chemical company that develops plasma-derived medicines and other biopharmaceuticals for patients with chronic and rare diseases. Founded in 1909 in Barcelona, the company has grown into a global leader in plasma collection and fractionation, with operations spanning biopharma, diagnostics, bio supplies, and hospital healthcare solutions. The company is publicly traded and has been recognized by TIME magazine and Forbes as one of the world's best companies and employers for multiple consecutive years.

About LFB

The LFB Group is a leading French biopharmaceutical laboratory dedicated to providing healthcare professionals with critical medicinal products derived from plasma or recombinant proteins. Operating with a strong public health mission, it serves as an essential link between plasma donors and patients, developing and manufacturing biomedicines for serious, chronic, and rare diseases. With nearly 3,100 employees worldwide and sales of €599.6 million in 2024, LFB is a key player in ensuring therapeutic sovereignty in France while expanding its international footprint across Europe, the Americas, and other global markets.

Therapeutic Areas